Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Radiation Oncology
•
Palliation
What is your preferred approach for palliation of gynecologic malignancies?
Would your your dose/fractionation recommendation change for patients with >1 year life expectancy?
Related Questions
How would you elect to treat a patient with asymptomatic vertebral metastasis after vertebral augmentation?
How have the results of the phase III RTOG 0631 trial impacted your use of spine SBRT?
What is the role of palliative radiation for bone/soft tissue metastases obliterating a joint space?
When considering re-irradiation of a critical organ, should EQD2 or BED be utilized?
How do you approach the management of a patient with lumbar spinal metastasis with neurologic symptoms but without evidence of spinal cord compression?
When planning spine SBRT, do you use volume dose limits to the spinal cord PRV, such as D0.35cc, in addition to maximum point dose?
Is there a contraindication to spine radiation in patient with an ATM mutation?
Do you modify the whole brain radiation dose if a patient has previously been treated with SRS for brain metastases?
What criteria do you use to decide whether to start anticonvulsants in patients with brain metastases?
How do you counsel patients with sleep disturbance secondary to chronic steroid use?